Content » Vol 67, Issue 5

Delayed pressure urticaria syndrome: a clinical expression of interleukin 1

Shelley WB, Shelley ED.
DOI: 10.2340/0001555567438441


Study of a patient with the bullous delayed pressure urticaria syndrome showed remarkable congruence of the extra-cutaneous findings and the known effects of interleukin 1: malaise, fever, myalgia, arthralgia, leukocytosis, increased sedimentation rate, and circulating acute phase reactants. As a result of this "clinical assay" for interleukin 1, we conclude that the delayed pressure urticaria syndrome is the clinical expression of interleukin 1, synthesized in the skin as a result of pressure and released into the circulation. Delayed urticaria, mediated by interleukin 1, is to be contrasted with immediate type urticaria, long known to be histamine mediated.


Supplementary content


Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.